About okyo pharma corp - OKYO
OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK geographical segments. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.
OKYO At a Glance
OKYO Pharma Ltd.
107 Cheapside
London, Greater London EC2V 6DN
| Phone | 44-20-7495-2379 | Revenue | 0.00 | |
| Industry | Biotechnology | Net Income | -4,706,292.00 | |
| Sector | Health Technology | Employees | N/A | |
| Fiscal Year-end | 03 / 2026 | |||
| View SEC Filings |
OKYO Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -6.761 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | N/A |
OKYO Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
OKYO Liquidity
| Current Ratio | 0.398 |
| Quick Ratio | 0.398 |
| Cash Ratio | 0.169 |
OKYO Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -180.366 |
| Return on Equity | N/A |
| Return on Total Capital | 84.805 |
| Return on Invested Capital | N/A |
OKYO Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |